Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial. - Perugino C; Culver EL; Khosroshahi A; Zhang W; Della-Torre E; Okazaki K; Tanaka Y; Löhr M; Schleinitz N; Falloon J; She D; Cimbora D; et al. (Rheumatology and therapy, 2023)